BIOWIRE2K. CAMBRIDGE, Mass.--(BUSINESS WIRE)--March 15, 2006-- Pioneer in High-Speed, High-Sensitivity Sequencing Receives Major Investment from Top-Tier Venture Capital Firms in Support of "true Single Molecule Sequencing" (tSMS(TM)) Technologies and Techniques. Helicos BioSciences, a pioneer in high-speed, high-sensitivity DNA sequencing, today announced that it has secured new investments totaling $40 million from a syndicate of top-tier venture capital firms, in support of the company's development of "true Single Molecule Sequencing" (tSMS(TM)) technologies and techniques.
